Shares of Cigna CI moved higher by 0.7% in pre-market trading after the company reported Q2 results.
Quarterly Results
Earnings per share were up 35.12% year over year to $5.81, which beat the estimate of $5.15.
Revenue of $39,205,000,000 up by 14.05% year over year, which beat the estimate of $37,750,000,000.
Looking Ahead
The upcoming fiscal year's EPS expected to be between $18.00 and $18.60.
The upcoming fiscal year's revenue expected to be between $154,000,000,000 and $156,000,000,000.
How To Listen To The Conference Call
Date: Jul 30, 2020
Time: 08:30 AM
ET Webcast URL: https://edge.media-server.com/mmc/p/ya4559xg
Price Action
Company's 52-week high was at $224.64
Company's 52-week low was at $118.50
Price action over last quarter: down 1.97%
Company Profile
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM services were greatly expanded by its 2018 merger with Express Scripts and are mostly sold to health insurance plans and employers. Its largest PBM contract after Anthem will be with the Department of Defense. In health insurance and other benefits, Cigna mostly serves employers through self-funding arrangements, but it also operates in government programs, such as Medicare Advantage and the individual exchanges. The company operates mostly in the U.S., but its services extend internationally in over 30 countries.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
